Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M110Revenue $M9.7Net Margin (%)16.0Z-Score-3.5
Enterprise Value $M61.6EPS $-2.4Operating Margin %-10.9F-Score6
P/E(ttm))36.3Cash Flow Per Share $0Pre-tax Margin (%)16.0Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %-41.5Quick Ratio9.0Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %-23.7Current Ratio9.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)9.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M14.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARDM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARDMJean-Marie Eveillard 2014-06-30 Buy 0.08%$0.185 - $9.52
($3.37)
$ 7.46121%New holding, 3854730 sh.3,854,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARDM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARDM Jean-Marie Eveillard 2014-09-303,854,73026.20.09
Premium Most recent portfolio changes are included for Premium Members only!


ARDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THOMPSON VIRGILDirector 2013-12-13Sell84$6.89.71view
Grifols SADirector, 10% Owner 2013-08-27Sell0$09.71view
Boxer Capital, LLC10% Owner 2013-05-20Sell0$09.71view
DEF Associates Ltd.See footnote below 2012-01-01Sell0$09.71view
DEF Associates LPSee Footnote 1 below 2010-12-31Sell0$09.71view
First Eagle Value in BiotechnoSee remarks. 2009-02-23Sell0$09.71view
First Eagle Value in Biotechno10% Owner 2009-02-23Sell0$09.71view
Grimes D JefferyVP Legal Affairs, Secretary 2008-07-01Sell0$09.71view
RA Capital Biotech Fund II, L.10% Owner 2007-03-01Sell0$09.71view
TANG KEVIN C10% Owner 2007-01-25Sell0$09.71view

Press Releases about ARDM :

    Quarterly/Annual Reports about ARDM:

    News about ARDM:

    Articles On GuruFocus.com
    Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 
    Eveillard’s First Eagle Seizes 45% of Pharamaceutical Company, Aradigm Dec 19 2012 

    More From Other Websites
    ARADIGM CORP Financials Nov 15 2014
    Aradigm to Present at the Stifel Healthcare Conference 2014 Nov 12 2014
    Aradigm to Present at the Stifel Healthcare Conference 2014 Nov 12 2014
    10-Q for Aradigm Corp. Nov 09 2014
    ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 07 2014
    Aradigm Announces Third Quarter 2014 Financial Results Nov 07 2014
    Aradigm Announces Third Quarter 2014 Financial Results Nov 07 2014
    Aradigm (ARDM) Downgraded From Hold to Sell Oct 31 2014
    Aradigm (ARDM) Falls: Stock Goes Down 5.2% Sep 23 2014
    Aradigm (ARDM) Upgraded From Sell to Hold Sep 22 2014
    Aradigm (ARDM) is in Overbought Territory: What's Next? Sep 12 2014
    Aradigm Corporation (ARDM) Up: Stock Adds 9.7% in Session Sep 11 2014
    FDA Grants Fast Track Designation to Aradigm’s Pulmaquin for Non-Cystic Fibrosis Bronchiectasis Sep 04 2014
    ARADIGM CORP Files SEC form 10-Q, Quarterly Report Aug 11 2014
    ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 08 2014
    Aradigm Announces Second Quarter 2014 Financial Results Aug 07 2014
    Aradigm to Host Analyst Meeting and Webcast on August 12 in New York City Aug 06 2014
    Aradigm to Host Corporate Update Conference Call on June 26 Jun 25 2014
    ARADIGM CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 09 2014
    Aradigm receives $5M milestone for dosing of first patient in Phase III study Jun 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK